Dr. Mohammad Alhousani is an Assistant Professor of Medicine at the Medical University of South Carolina (MUSC) with expertise in lymphomas and related B- and T-cell disorders, including both aggressive and indolent non-Hodgkin lymphomas, Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenström macroglobulinemia, and central nervous system (CNS) lymphoma. Dr. Alhousani's clinical and research interests focus on bringing the latest advances in lymphoma care to his patients. He has a particular interest in CAR T-cell therapy, bispecific antibodies, clinical trials, and blood and marrow transplantation for patients with lymphoma. His approach emphasizes integrating innovative therapies with personalized, compassionate care tailored to each patient's needs and goals. He completed his internal medicine residency at Marshall University and his hematology and oncology fellowship at Allegheny Health Network (AHN). He then pursued an advanced fellowship in Blood and Marrow Transplantation at Mayo Clinic in Rochester, Minnesota, where he was deeply involved in the care of patients with lymphoma and CAR T-cell therapy. Dr. Alhousani is committed to advancing the field of lymphoma and cellular therapy through clinical research, multidisciplinary collaboration, and a patient-centered approach to cancer care.
He is actively involved in clinical research, co-authoring 4 peer reviewed articles.
Hematology Oncology
Hematology
Oncology
